Patients with the diagnosis of CHD who underwent HT were identified. Multiple recipient and donor variables were examined to identify risk factors for survival after transplan- tation. Recipient variables included CHD diagnosis, United Network for Organ Sharing status at transplantation, sur- gical history, and listing hemodynamics. Pulmonary vascular resistance and percent reactive antibody data were not available for analysis Donor variables included echocardio graphic and angiographic data, cause of death, inotropic support, and cytomegalovirus mismatch. Data were ana lyzed using Kaplan-Meier survival and nonparametric and parametric hazard models. Survival was compared among patients with CHD and those with cardiomyopathy